| |
| |
|
| Insider
Information: |
Matsui Connie |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
273,009 |
|
|
Indirect Shares
|
40,766 |
|
|
| Direct
Value |
$13,468,822 |
|
|
|
Indirect Value
|
$8,879,242 |
|
|
| Total
Shares |
313,775 |
|
|
| Total
Value |
$22,348,064 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
2.0
|
| Percentage
Gain/Loss : |
 -16.5%
|
 66.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
EVP, Corp. Strategy an... |
2007-02-12 |
22,837 |
2007-02-12 |
40,766 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
|
2024-04-25 |
193,505 |
|
0 |
Premium* |
|
|
Artelo Biosciences, Inc. |
ARTL |
|
2020-05-04 |
56,667 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2010-05-06 |
4 |
A |
$0.00 |
$20 |
D/D |
20,000 |
85,000 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2004-05-18 |
4 |
S |
$59.02 |
$3,542,600 |
D/D |
(60,000) |
87,998 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2004-08-20 |
4 |
OE |
$6.92 |
$553,336 |
D/D |
80,000 |
87,998 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2006-04-28 |
4 |
AS |
$44.92 |
$1,806,700 |
D/D |
(40,000) |
96,825 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2011-05-05 |
4 |
A |
$0.00 |
$20 |
D/D |
20,000 |
105,000 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2004-05-18 |
4 |
OE |
$6.92 |
$415,002 |
D/D |
60,000 |
107,998 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2012-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
125,000 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
officerTitle |
• – – |
2005-10-12 |
4 |
AS |
$36.36 |
$1,414,625 |
D/D |
(38,771) |
136,825 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2006-04-28 |
4 |
OE |
$7.72 |
$308,752 |
D/D |
40,000 |
136,825 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2013-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
145,000 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2005-01-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,725 |
154,846 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2004-12-23 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,720 |
156,571 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp Strategy & CommEVP, |
• – – |
2003-11-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,051 |
159,284 |
|
- |
|
| BIIB |
Biogen Idec Inc |
officerTitle |
• – – |
2003-08-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,000 |
165,397 |
|
- |
|
| BIIB |
Biogen Idec Inc |
Sr V P, Planning& Resource Dev |
• – – |
2003-11-19 |
4 |
S |
$35.04 |
$1,401,780 |
D/D |
(40,000) |
165,397 |
|
- |
|
| BIIB |
Biogen Idec Inc |
Sr V P, Planning& Resource Dev |
• – – |
2003-11-25 |
4 |
OE |
$7.72 |
$30,397 |
D/D |
3,938 |
169,335 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2014-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
24,876 |
169,876 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP - Corp Comm & Strategy |
• – – |
2004-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,990 |
170,274 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2004-05-18 |
4/A |
S |
$59.02 |
$3,542,600 |
D/D |
(60,000) |
170,274 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
officerTitle |
• – – |
2003-03-31 |
4 |
A |
$29.09 |
$10,675 |
D/D |
367 |
172,397 |
|
- |
|
| BIIB |
Biogen Idec Inc |
officerTitle |
• – – |
2005-10-12 |
4 |
OE |
$7.72 |
$299,266 |
D/D |
38,771 |
175,596 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
|
– • – |
2022-11-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,250 |
178,939 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2021-11-05 |
4 |
S |
$40.13 |
$1,292,113 |
D/D |
(32,000) |
181,983 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
13,175 |
183,051 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
|
– • – |
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
8,065 |
187,004 |
0 |
- |
|
65 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
